Parallel synthesis of peptide-like macrocycles containing imidazole-4,5-dicarboxylic acid

Molecules

Volumn 17, Issue 5, 2012, Pages 5346-5362

  Xu, Zhigang ^a   Wheeler, Kraig A ^b   Baures, Paul W ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b EASTERN ILLINOIS UNIVERSITY   (United States)

^c KEENE STATE COLLEGE   (United States)

Author keywords

Imidazole 4,5 dicarboxylic acid; Library synthesis; Macrocycle; Scaffold

Indexed keywords

AMINO ACID; DICARBOXYLIC ACID; IMIDAZOLE DERIVATIVE; PEPTIDOMIMETIC AGENT;

AMINO ACID SUBSTITUTION; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG DEVELOPMENT; HYDROGEN BOND; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SUBSTITUTION; AMINO ACIDS; CRYSTALLOGRAPHY, X-RAY; DICARBOXYLIC ACIDS; DRUG DISCOVERY; HYDROGEN BONDING; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PEPTIDOMIMETICS;

EID: 84861494704     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17055346     Document Type: Article

References (46)

1. Walsh, C.T. The chemical versatility of natural-product assembly lines. Acc. Chem. Res. 2008, 41, 4-10.
2. König, G.M.; Kehraus, S.; Seibert, S.F.; Abdel-Lateff, A.; Müller, D. Natural products from marine organisms and their associated microbes. ChemBioChem 2006, 7, 229-238.
3. Dunlap, W.C.; Battershill, C.N.; Liptrot, C.H.; Cobb, R.E.; Bourne, D.G.; Jaspars, M.; Long, P.F.; Newman, D.J. Biomedicinals from the phytosymbionts of marine invertebrates: A molecular approach. Methods 2007, 42, 358-376.
4. Tan, N.-H.; Zhou, J. Plant cyclopeptides. Chem. Rev. 2006, 106, 840-895.
5. Veber, D.F.; Holly, F.W.; Nutt, R.F.; Bergstrand, S.J.; Brady, S.F.; Hirschmann, R.; Glitzer, M.S.; Saperstein, R. Highly active cyclic and bicyclic somatostatin analogues of reduced ring size. Nature 1979, 280, 512-514.
6. Veber, D.F.; Freidlinger, R.M.; Perlow, D.S.; Paleveda, W.J., Jr.; Holly, F.W.; Stachan, R.G.; Nutt, R.F.; Arison, B.H.; Homnick, C.; Randall, W.C.; et al. A potent cyclic hexapeptide analogue of somatostatin. Nature 1981, 292, 55-58.
7. Vagner, J.; Qu, H.; Hruby, V.J. Peptidomimetics, a synthetic tool of drug discovery. Curr. Opin. Chem. Biol. 2008, 12, 292-296.
8. Janin, Y.L. Peptides with anticancer use or potential. Amino Acids 2003, 25, 1-40.
9. Perez, L.J.; Faulkner, D.J. Bistratamides E-J, modified cyclic hexapeptides from the Philippines ascidian Lissoclinum bistratum. J. Nat. Prod. 2003, 66, 247-250.
10. Hughes, R.A.; Moody, C.J. From amino acids to heteroaromatics-Thiopeptide antibiotics, nature's heterocyclic peptides. Angew. Chem. Int. Ed. Engl. 2007, 46, 7930-7954.
11. Bertram, A.; Blake, A.J.; de Turiso, F.G.-L.; Hannam, J.S.; Jolliffe, K.A.; Pattenden, G.; Skae, M. Concise synthesis of stereodefined, thiazole-containing cyclic hexa- and octapeptide relatives of the Lissoclinums, via cyclooligomerisation reactions. Tetrahedron 2003, 59, 6979-6990.
12. Bertram, A.; Maulucci, N.; New, O.M.; Nor, S.M.M.; Pattenden, G. Synthesis of libraries of thiazole, oxazole, and imidazole-based cyclic peptides from azole-based amino acids. A new synthetic approach to Bistratamides and Didmolamides. Org. Biomol. Chem. 2007, 5, 1541-1553.
13. Haberhauer, G.; Drosdow, E.; Oeser, T.; Rominger, F. Structural investigation of Westiellamide analogues. Tetrahedron 2008, 64, 1853-1859.
14. Ying, Y.; Taori, K.; Kim, H.; Hong, J.; Luesch, H. Total synthesis and molecular target of Largazole, a histone deacetylase inhibitor. J. Am. Chem. Soc. 2008, 130, 8455-8459.
15. You, S.-L.; Kelly, J.W. Highly efficient biomimetic total synthesis and structural verification of Bistratamides E and J from Lissoclinum bistratum. Chem. Eur. J. 2004, 10, 71-75.
16. You, S.-L.; Deechongkit, S.; Kelly, J.W. Solid-phase synthesis and stereochemical assignments of Tenuecyclamides A-D employing heterocyclic amino acids derived from commercially available Fmoc a-amino acids. Org. Lett. 2004, 6, 2627-2630.
17. Abo-Ghalia, M.; Amr, A. Synthesis and investigation of a new cyclo(Na-dipicolinyl)pentapeptide of a breast and CNS cytotoxic activity and an ionophoric specificity. Amino Acids 2004, 26, 283-289.
18. Springer, J.; de Cuba, K.R.; Calvet-Vitale, S.; Geenevasen, J.A.J.; Hermkens, P.H.H.; Hiemstra, H.; van Maarseveen, J.H. Backbone amide linker strategy for the synthesis of 1,4-triazole-containing cyclic tetra- and pentapeptides. Eur. J. Org. Chem. 2008, 2008, 2592-2600.
19. Chen, W.; Yang, J.Z.; Andersen, R.; Nielsen, L.H.; Borchardt, R.T. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model. J. Pharmacol. Exp. Ther. 2002, 303, 849-857.
20. Hess, S.; Ovadia, O.; Shalev, D.E.; Senderovich, H.; Qadri, B.; Yehezkel, T.; Salitra, Y.; Sheynis, T.; Jelinek, R.; Gilon, C.; et al. Effect of structural and conformational modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability. J. Med. Chem. 2007, 50, 6201-6211.
21. Liederer, B.M.; Phan, K.T.; Ouyang, H.; Borchardt, R.T. Significant differences in the disposition of cyclic prodrugs of opioid peptides in rats and guinea pigs following IV administration. J. Pharm. Sci. 2005, 94, 2676-2687.
22. Liederer, B.M.; Fuchs, T.; Vander Velde, D.; Siahaan, T.J.; Borchardt, R.T. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides. J. Med. Chem. 2006, 49, 1261-1270.
23. Linde, Y.; Ovadia, O.; Safrai, E.; Xiang, Z.; Portillo, F.P.; Shalev, D.E.; Haskell-Luevano, C.; Hoffman, A.; Gilon, C. Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides. Biopolymers 2008, 90, 671-682.
24. Malakoutikhah, M.; Teixidó, M.; Giralt, E. Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries. J. Med. Chem. 2008, 51, 4881-4889.
25. Ouyang, H.; Andersen, T.E.; Chen, W.; Nofsinger, R.; Steffansen, B.; Borchardt, R.T. A comparison of the effects of P-glycoprotein inhibitors on the blood-brain barrier permeation of cyclic prodrugs of an opioid peptide (DADLE). J. Pharm. Sci. 2009, 98, 2227-2236.
26. Rezai, T.; Yu, B.; Millhauser, G.L.; Jacobson, M.P.; Lokey, R.S. Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers. J. Am. Chem. Soc. 2006, 128, 2510-2511.
27. Wang, D.; Liao, W.; Arora, P.S. Enhanced metabolic stability and protein-binding properties of artificial a-helices derived from a hydrogen-bond surrogate: Application to Bcl-xL. Angew. Chem. Int. Ed. Engl. 2005, 44, 6525-6529.
28. Terrett, N.K. Methods for the synthesis of macrocycle libraries for drug discovery. Drug Discov. Today Technol. 2010, 7, e97-e104.
29. Isidro-Llobet, A.; Murillo, T.; Bello, P.; Cilibrizzi, A.; Hodgkinson, J.T.; Galloway, W.R.J.D.; Bender, A.; Welch, M.; Spring, D.R. Diversity-oriented synthesis of macrocyclic peptidomimetics. Proc. Natl. Acad. Sci. USA 2011, 108, 6793-6798.
30. Baures, P.W. Imidazole-4,5-dicarboxylic acid: A versatile scaffold for drug discovery and materials research. Trends Heterocycl. Chem. 2006, 11, 1-22.
31. Xu, Z.; DiCesare, J.C.; Baures, P.W. Parallel synthesis of an oligomeric imidazole-4,5-dicarboxamide library. J. Comb. Chem. 2010, 12, 248-254.
32. Solinas, R.; DiCesare, J.C.; Baures, P.W. Parallel synthesis of a library of symmetrically and disymmetrically-disubstituted imidazole-4,5-dicarboxamides bearing amino acid esters. Molecules 2009, 14, 352-363.
33. Solinas, R.; DiCesare, J.C.; Baures, P.W. Parallel synthesis of an imidazole-4,5-dicarboxylic acid library bearing amino acid esters and alkanamines. Molecules 2008, 13, 3149-3170.
34. Lipinski, C.A.; Lombarto, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Deliv. Rev. 1997, 23, 3-25.
35. Lipinski, C.A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 2000, 44, 235-249.
36. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001, 46, 3-26.
37. Veber, D.F.; Johnson, S.R.; Cheng, H.Y.; Smith, B.R.L; Ward, K.W.; Kopple, K.D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002, 45, 2615-2623.
38. Lipinski, C.A. Lead- and drug-like compounds: The rule of five revolution. Drug Discov. Today 2004, 1, 337-341.
39. de Groot, F.M.H.; Loos, W.J.; Koekkoek, R.; van Berkom, L.W.A.; Busscher, G.F.; Seelen, A.E.; Albrecht, C.; de Bruijn, P.; Scheeren, H.W. Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release. J. Org. Chem. 2001, 66, 8815-8830.
40. Marugan, J.J.; Zheng, W.; Motabar, O.; Southall, N.; Goldin, E.; Westbroek, W.; Stubblefield, B.K.; Sidransky, E.; Aungst, R.A.; Lea, W.A.; et al. Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity. J. Med. Chem. 2011, 54, 1033-1058.
41. Shao, Y.-M.; Yang, W.-B.; Kuo, T.-H.; Tsai, K.-C.; Lin, C.-H.; Yang, A.-S.; Liang, P.-H.; Wong, C.-H. Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease. Bioorg. Med. Chem. 2008, 16, 4652-4660.
42. Spartan'06. Wavefunction, Inc.: Irvine, CA, USA, 2006.
43. Shao, Y.; Molnar, L.F.; Jung, Y.; Kussmann, J.; Ochsenfeld, C.; Brown, S.T.; Gilbert, A.T.B.; Slipchenko, L.V.; Levchenko, S.V.; O'Neill, D.P.; et al. Advances in methods and algorithms in a modern quantum chemistry program package. Phys. Chem. Chem. Phys. 2006, 8, 3172-3191.
44. Rush, J.R.; Sandstrom, S.L.; Yang, J.; Davis, R.; Prakash, O.; Baures, P.W. Intramolecular hydrogen bond strength and pKa determination of N,N'-disubstituted imidazole-4,5-dicarboxamides. Org. Lett. 2005, 7, 135-138.
45. Baures, P.W.; Rush, J.R.; Wiznycia, A.V.; Desper, J.; Helfrich, B.A.; Beatty, A.M. Intramolecular hydrogen bonding and intermolecular dimerization in the crystal structures of imidazole-4,5- dicarboxylic acid derivatives. Cryst. Growth Des. 2002, 2, 653-664.
46. Sheldrick, G.M. SHELXL-93; University of Göttingen: Göttingen, Germany, 1993.